Closed Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The National Institutes of Health is seeking proposals for the Groundbreaking Lymphatic Interventions and Drug Exploration (GLIDE) program, with a Solution Summary due date of December 12, 2024. Recent amendments have updated the solicitation and FAQ documents. Bidders should monitor SAM.gov and grants.gov for the full Innovative Solutions Opening (ISO) details, as the draft ISO is subject to updates.
January 15, 2025: The solicitation is updated to update the FAQ document with questions related to Pitch Presentations.
December 6, 2024: Amendment 2 is issued to extend the Solution Summary due date. The new Solution Summary due date is December 12, 2024.
November 7, 2024: Amendment 1 is issued to correct a typographical error of the Solution Summary due date. The correct Solution Summary due date is December 2, 2024.
October 29, 2024: The solicitation is updated to add the full ISO along with Attachments 1, 2, 3a, and 3b. Information in the full ISO supersedes any information presented in the draft ISO, Proposers' Day slides and presentations, and any other publications.
**************************
October 28, 2024: The solicitation is updated to update the FAQ document. The due date for solution summaries for GLIDE will be released when the full ISO is launched. The currently posted ISO is a draft and will be updated with the forthcoming publication of the full ISO. Note, the solution summary due date will be at least 30 days after the full ISO has been posted. Please keep checking SAM.gov and grants.gov for the full ISO.
October 15, 2024: The solicitation is updated to update the FAQ document.
September 26, 2024: The solicitation is updated to update the FAQ document.
September 4, 2024: The solicitation is updated to update the FAQ document.
August 16, 2024: The solicitation is updated to add the FAQ document and amend the DRAFT ISO.
The Advanced Research Projects Agency for Health (ARPA-H) is posting this DRAFT Innovative Solutions Opening (ISO) ARPA-H-SOL-24-111 for the Groundbreaking Lymphatic Interventions and Drug Exploration (GLIDE) Program in order to help potential proposers prepare for Proposer's Day and plan for solution summary submission.
The finalized ISO and related attachments will be posted at a later date.
GROUNDBREAKING LYMPHATIC INTERVENTIONS AND DRUG EXPLORATION (GLIDE) is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.